Biosimilars Knowledge Connect - QuintilesIMS

Join QuintilesIMS biosimilar investigator network to improve access to biologics for patients around the world. Significant clinical benefit but unaffordable for many. And they are forecast to account for more than 70 of new drug approvals by 2025. However, the high cost of biologics puts them out of reach of patients in many countries. The situation is becoming unsustainable for even the most developed nations. Biosimilars highly similar, more affordable successors to originator biologics. Clinical t.

OVERVIEW

The web page biosimilarsknowledgeconnect.com presently has an average traffic ranking of zero (the smaller the better). There is two contacts and locations for biosimilarsknowledgeconnect.com to help you connect with them. The web page biosimilarsknowledgeconnect.com has been online for six hundred and thirty-two weeks, ten days, fifteen hours, and thirty-four minutes.
Contacts
2
Addresses
2
Online Since
Aug 2012

BIOSIMILARSKNOWLEDGECONNECT.COM TRAFFIC

The web page biosimilarsknowledgeconnect.com is seeing diverging amounts of traffic through the year.
Traffic for biosimilarsknowledgeconnect.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for biosimilarsknowledgeconnect.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for biosimilarsknowledgeconnect.com

Date Range

All time
This Year
Last Year
Last Month

BIOSIMILARSKNOWLEDGECONNECT.COM HISTORY

The web page biosimilarsknowledgeconnect.com was first recorded on August 30, 2012. It was changed on September 03, 2013. This website will go back on the market on the date of August 30, 2015. As of today, it is six hundred and thirty-two weeks, ten days, fifteen hours, and thirty-four minutes old.
REGISTERED
August
2012
UPDATED
September
2013
EXPIRED
August
2015

AGE

12
YEARS
1
MONTHS
10
DAYS

LINKS TO BIOSIMILARSKNOWLEDGECONNECT.COM

WHAT DOES BIOSIMILARSKNOWLEDGECONNECT.COM LOOK LIKE?

Desktop Screenshot of biosimilarsknowledgeconnect.com Mobile Screenshot of biosimilarsknowledgeconnect.com Tablet Screenshot of biosimilarsknowledgeconnect.com

CONTACTS

Quintiles Transnational Corp.

4820 Emperor Blvd

Durham, NC, 27703

US

Quintiles Transnational Corp.

Quintiles Transnational Corp.

4820 Emperor Blvd

Durham, NC, 27703

US

BIOSIMILARSKNOWLEDGECONNECT.COM SERVER

I diagnosed that a lone page on biosimilarsknowledgeconnect.com took five hundred and thirteen milliseconds to stream. I could not observe a SSL certificate, so our web crawlers consider this site not secure.
Load time
0.513 sec
SSL
NOT SECURE
IP
174.143.17.176

NAME SERVERS

ns75.worldnic.com
ns76.worldnic.com

FAVICON

SERVER SOFTWARE AND ENCODING

We caught that this domain is employing the Microsoft-IIS/7.5 operating system.

SITE TITLE

Biosimilars Knowledge Connect - QuintilesIMS

DESCRIPTION

Join QuintilesIMS biosimilar investigator network to improve access to biologics for patients around the world. Significant clinical benefit but unaffordable for many. And they are forecast to account for more than 70 of new drug approvals by 2025. However, the high cost of biologics puts them out of reach of patients in many countries. The situation is becoming unsustainable for even the most developed nations. Biosimilars highly similar, more affordable successors to originator biologics. Clinical t.

PARSED CONTENT

The web page states the following, "Join QuintilesIMS biosimilar investigator network to improve access to biologics for patients around the world." I viewed that the web page also said " Significant clinical benefit but unaffordable for many." They also said " And they are forecast to account for more than 70 of new drug approvals by 2025. However, the high cost of biologics puts them out of reach of patients in many countries. The situation is becoming unsustainable for even the most developed nations. Biosimilars highly similar, more affordable successors to originator biologics."

SEE SUBSEQUENT WEB SITES

Biosimilars Law Blog Pharmaceutical Lawyers Hogan Lovells

With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Posted in News and Events. Biosimilars Presentation at Sino-American Pharmaceutical Conference. On June 24, 2017, Hogan Lovells attorneys Xin Tao. This event drew over 1,000 people from both the Chinese and U. Link to the event is available here.

Patients for Biologics Safety Access

Patients for Biologics Safety and Access. Patients for Biologics Safety and Access. Have the potential to impact millions of lives. Policymakers need to hear a strong and united patient voice at this critical time. Follow PBSA on social medi.

Andrey Gurtovenko research home page

org is a research website of Andrey Gurtovenko. J Phys Chem Lett publication. Two papers on biomedical applications of cationic polymers.

Welcome to Biosincron! - Biosincron

We offer high quality beauty and massage tools. All of our products are available through Amazon. Check out our Amazon Store Front.